Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from DOCS

Google Docs AI Open to Prompt Injection Attacks, Exposing Users to Phishing or Misinformation

Adding a prompt in your document will cause the 'refine text' to follow it, changing the output and leaving readers open to phishing.

Tom’s Hardware · Jul 14, 2023

Google Docs' 'pageless' mode is no longer the default view on Android

Google Docs will now open documents in paginated mode when you first open it on a mobile phone or tablet.

Android Central · Jun 14, 2023

County directors unite to demand greater say in how domestic game is run

The DOCs feel there is an “urgent need for a review of the standard player contract”.

The Independent UK · May 24, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Google Docs is getting a whole lot smarter - and collapsable?

Collapsible headings, with definable default states, are coming to Google Docs - should you want that.

TechRadar · May 17, 2023

Google wants you to help sculpt the future of AI - here's how you can get involved

Gmail and Google Docs are one step closer to getting full AI support, but users outside the US are left waiting.

TechRadar · May 5, 2023

Best Google Docs Add-ons for Teachers

Get the best Google Docs Add-ons to help make teaching easier and more effective.

Tech&Learning · Apr 26, 2023

Looking At Doximity's Recent Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bullish stance on Doximity. Looking at options history for Doximity (NYSE:DOCS) we detected 18 strange trades.

Benzinga · Nov 11, 2022

Read news from The Economist, FT, and more,
with one subscription

Is This Health Care Stock Still a Good Play 1 Year After Its IPO?

Doximity Inc. (DOC) made its stock market debut on June 25, 2021. However, the stock has lost 19.2% over the past year. So, let’s evaluate if it is worth buying the stock now….

StockNews.com · Jul 15, 2022

Stock Split or Not: 3 Stock to Avoid

Amid the stock split trend, irrespective of whether Shopify (SHOP), MercadoLibre (MELI), and Doximity (DOCS) are undergoing a stock split in the near term or not, these stocks aren’t well-positioned to survive the market slump. So, they are best avoided now. Let’s discuss….

StockNews.com · Jul 4, 2022

If You’d Like To Dabble In The 80s Fashion Resurgence This Winter, We’ve Found The Perfect ’Fits

Big hair not included.

Pedestrian.tv · May 31, 2022

Looking At Doximity's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Doximity (NYSE:DOCS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · May 18, 2022

What 5 Analyst Ratings Have To Say About Doximity

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Benzinga · May 18, 2022

Why Doximity Shares Are Trading Lower After Hours

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted net income was $44.9 million versus $24 million in 4Q21, representing a 48% margin. Adjusted EPS was $0.21, beating the consensus of $0.15. Adjusted gross margin expanded by 200 bps to 90%.…

Benzinga · May 17, 2022

Is Doximity a Good Growth Stock to Own?

Shares of Doximity (DOCS), a cloud-based digital platform for medical professionals, recently reported impressive third-quarter financials, beating the consensus EPS estimate. However, is it wise to buy the stock amid the subdued climate for growth companies? Let’s find out.

StockNews.com · Feb 24, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Feb 9, 2022

Where Doximity Stands With Analysts

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Benzinga · Feb 9, 2022

Why Doximity Shares Are Trading Higher Premarket Today?

Doximity Inc (NYSE: DOCS) posted Q3 FY22 sales of $9

Advnture · Dec 3, 2021

Can you hike in Doc Martens? We take a look

Can you hike in Doc Martens? We set gear snobbery aside and weigh function over fashion to provide the answer to this oft-asked question

1 2

Coverage From

People

Albert Einstein

738 stories

Mangeet Kaur BounsMangeet

595 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.